Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
| Autor: | Viviane O. Leal, Ludmila F M F Cardozo, Milena B. Stockler-Pinto, Denise Mafra, Karen Salve Coutinho-Wolino |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
030109 nutrition & dietetics Nutrition and Dietetics biology Metabolite Medicine (miscellaneous) 030209 endocrinology & metabolism Context (language use) Trimethylamine N-oxide Neural degeneration Gut flora Pharmacology biology.organism_classification medicine.disease 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Insulin resistance chemistry medicine Choline Carnitine medicine.drug |
| Zdroj: | European Journal of Nutrition. 60:3567-3584 |
| ISSN: | 1436-6215 1436-6207 |
| DOI: | 10.1007/s00394-021-02491-6 |
| Popis: | Trimethylamine N-oxide (TMAO) is a metabolite that has attracted attention due to its positive association with several chronic non-communicable diseases such as insulin resistance, atherosclerotic plaque formation, diabetes, cancer, heart failure, hypertension, chronic kidney disease, liver steatosis, cardiac fibrosis, endothelial injury, neural degeneration and Alzheimer's disease. TMAO production results from the fermentation by the gut microbiota of dietary nutrients such as choline and carnitine, which are transformed to trimethylamine (TMA) and converted into TMAO in the liver by flavin-containing monooxygenase 1 and 3 (FMO1 and FMO3). Considering that TMAO is involved in the development of many chronic diseases, strategies have been found to enhance a healthy gut microbiota. In this context, some studies have shown that nutrients and bioactive compounds from food can modulate the gut microbiota and possibly reduce TMAO production. This review has as main objective to discuss the studies that demonstrated the effects of food on the reduction of this harmful metabolite. All relevant articles until November 2020 were included. The articles were searched in Medline through PubMed. Both the food is eaten acutely and chronically, by altering the nature of the gut microbiota, influencing colonic TMA production. Furthermore, hepatic production of TMAO by the flavin monooxygenases in the liver may also be influenced by phenolic compounds present in foods. The evidence presented in this review shows that TMAO levels can be reduced by some bioactive compounds. However, it is crucial to notice that there is significant variation among the studies. Further clinical studies should be conducted to evaluate these dietary components’ effectiveness, dose, and intervention time on TMAO levels and its precursors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|